Condition: Developmental and Epileptic Encephalopathy · Sponsor: Longboard Pharmaceuticals
This (DEEp OLE Study) is a multicentre, open-label study to investigate the long-term safety, efficacy, tolerability, and pharmacokinetics (PK) of LP352 in the treatment of seizures in children and adults with DEE who completed Study LP352-301 or LP352-302. The study consists of 3 main phases: Screening, Titration period and Maintenance period, followed by a Taper period and Follow-Up. The total duration of the study will be approximately 14 months.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arkansas Children's Hospital - PIN | Little Rock, Arkansas, United States | — |
| David Geffen School of Medicine at UCLA | Los Angeles, California, United States | — |
| The Stanford Division of Child Neurology | Palo Alto, California, United States | — |
| UCSF Children's Hospital | San Francisco, California, United States | — |
| Childrens Hospital Colorado - PIN | Aurora, Colorado, United States | — |
| NW FL Clinical Research Group, LLC | Gulf Breeze, Florida, United States | — |
| University of Miami - 1120 NW 14th St | Miami, Florida, United States | — |
| Research Institute of Orlando LLC | Orlando, Florida, United States | — |
| University of South Florida - 2 Tampa General Circle | Tampa, Florida, United States | — |
| Pediatric Epilepsy and Neurology Specialists | Tampa, Florida, United States | — |
| Consultants In Epilepsy and Neurology PLLC | Boise, Idaho, United States | — |
| Mid-Atlantic Epilepsy and Sleep Center | Bethesda, Maryland, United States | — |
+ 56 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.